Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4 type RangedSequencePosition NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA.assertion.
- NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4 type SO_0001148 NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA.assertion.
- NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4 comment "Increased constitutive kinase activity; when associated with F-319. About 75% loss of CD247/CD3Z-binding in stimulated TCR and complete loss of VAV1 interaction." NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA.assertion.
- NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4 SIO_000053 NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._5 NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA.assertion.
- NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._4 SIO_000053 NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA._6 NX_P43403-2_MUTAGEN_8_8.RALRYuH6ZjwCXzvtUu6pwRjAU_72C5w8IfKZ_5fysKfvA.assertion.